Comparação dos efeitos de dexmedetomidina administrada em dois momentos diferentes para lesão de isquemia/reperfusão renal em ratos

Thadhani, 1996, Acute renal failure, N Engl J Med, 334, 1448, 10.1056/NEJM199605303342207 Brezis, 1984, Renal ischemia: a new perspective, Kidney Int, 26, 375, 10.1038/ki.1984.185 Caron, 2004, Kidney ischemia reperfusion regulates expression and distribution of tubulin subunits, beta‐actin and rho GTPases in proximal tubules, Arch Biochem Biophys, 431, 31, 10.1016/j.abb.2004.07.009 Granger, 1995, Physiologic mechanisms of postischemic tissue injury, Annu Rev Physiol, 57, 311, 10.1146/annurev.ph.57.030195.001523 Brezis, 1995, Hypoxia of the renal medulla—its implications for disease, N Engl J Med, 332, 647, 10.1056/NEJM199503093321006 Chiao, 1997, Alpha‐melanocyte‐stimulating hormone protects against renal injury after ischemia in mice and rats, J Clin Invest, 99, 1165, 10.1172/JCI119272 Williams, 1997, Characterization of renal ischemia‐reperfusion injury in rats, J Pharmacol Toxicol Methods, 37, 1, 10.1016/S1056-8719(96)00141-4 Billings, 2008, Alpha‐2 adrenergic agonists protect against radiocontrast‐induced nephropathy in mice, Am J Physiol Renal Physiol, 295, 741, 10.1152/ajprenal.90244.2008 Wikberg, 1991, Medetomidine stereoisomers delineate two closely related subtypes of idazoxan (imidazoline) I‐receptors in the guinea pig, Eur J Pharmacol, 193, 335, 10.1016/0014-2999(91)90148-J Scheinin, 1987, Sedative and cardiovascular effects of medetomidine, a novel seletive alpha2‐adrenoceptor agonist, in healthy volunteers, Br J Clin Pharmacol, 24, 443, 10.1111/j.1365-2125.1987.tb03196.x Kallio, 1989, Effects of deksmedetomidine, a seletive alpha 2‐adrenoceptor agonist, on hemodynamic control mechanisms, Clin Pharmacol Ther, 46, 33, 10.1038/clpt.1989.103 Aho, 1992, Intramusculary administered deksmedetomidine attenuates hemodynamic and stress hormone responses to gynecologic laparoscopy, Anesth Analg, 75, 932, 10.1213/00000539-199212000-00011 Talke, 2000, The hemodynamic and adrenergic effects of perioperative deksmedetomidine infusion after vascular surgery, Anesth Analg, 90, 834, 10.1213/00000539-200004000-00011 Jalonen, 1997, Deksmedetomidine as an anesthetic adjunct in coronary artery bypass grafting, Anesthesiology, 86, 331, 10.1097/00000542-199702000-00009 Villela, 2005, Effects of dexmedetomidine on renal system and on vasopressin plasma levels. Experimental study in dogs, Rev Bras Anestesiol, 55, 429 Frumento, 2006, Deksmedetomidine infusion is associated with enhanced renal function after thoracic surgery, J Clin Anesth, 18, 422, 10.1016/j.jclinane.2006.02.005 Kocoglu, 2009, Effect of deksmedetomidine on ischemia‐reperfusion injury in rat kidney a histopathologic study, Renal Failure, 31, 70, 10.1080/08860220802546487 Feng, 2004, Effect of ligustrazine on ischemia‐reperfusion injury in murine kidney, Transplant Proc, 36, 1949, 10.1016/j.transproceed.2004.07.050 Fujii, 2003, Preventive effect of l‐carnosine on ischemia/reperfusion‐induced acute renal failure in rats, Eur J Pharmacol, 474, 261, 10.1016/S0014-2999(03)02079-X Hull, 2007, A new doctor for a men diabetes and hypertension;, 65 Hussein, 2011, Effects of combined erythropoietin and epidermal growth factor on renal ischaemia/reperfusion injury: a randomized experimental controlled study, BJU Int, 107, 323, 10.1111/j.1464-410X.2010.09328.x Gu, 2011, Dexmedetomidine provides renoprotection against ischemia‐reperfusion injury in mice, Crit Care, 15, 153, 10.1186/cc10283 Yamamoto, 1984, Outer medullary circulatory defect in ischemic acute renal failure, Am J Pathol, 116, 253 Arendshorst, 1975, Pathogenesis of acute renal failure following temporary renal ischemia in the rat, Circ Res, 37, 558, 10.1161/01.RES.37.5.558 Bird, 1988, Ischemic acute renal failure and antioxidant therapy in the rat: the relation between glomerular and tubular dysfunction, J Clin Invest, 81, 1630, 10.1172/JCI113498 Weinberg, 1991, The cell biology of ischemic renal injury, Kidney Int, 39, 476, 10.1038/ki.1991.58 Hoffman, 1991, Deksmedetomidine improves neurologic outcome from incomplete ischemia in the rat. Reversal by the alpha 2‐adrenergic antagonist atipamezole, Anesthesiology, 75, 328, 10.1097/00000542-199108000-00022 Maier, 1995, Neuroprotection by the N‐methyl‐d‐aspartate receptor antagonist CGP 40116: In vivo and in vitro studies, J Neurochem, 65, 652, 10.1046/j.1471-4159.1995.65020652.x Koçoğlu, 2008, Preconditioning effects of dexmedetomidine on myocardial ischemia/reperfusion injury in rats, Curr Ther Res, 69, 150, 10.1016/j.curtheres.2008.04.003 Simonson, 1993, Hydrogen peroxide production by monoamine oxidase during ischemia–reperfusion in the rat brain, J Cereb Blood Flow Metab, 13, 125, 10.1038/jcbfm.1993.15 Suzuki, 1995, MAO inhibitors, clorgyline and lazabemide, prevent hydroxyl radical generation caused by brain ischemiarreperfusion in mice, Pharmacology, 50, 357, 10.1159/000139304 Engelhard, 2003, The effect of the alpha 2‐agonist deksmedetomidine and the N‐methyl‐d‐aspartate antagonist S(+)‐ketamine on the expression of apoptosis regulating proteins after incomplete cerebral ischemia and reperfusion in rats, Anesth Analg, 96, 524, 10.1213/00000539-200302000-00041 Wijeysundera, 2003, Alpha‐2 adrenergic agonists to prevent perioperative cardiovascular complications: a meta‐analysis, Am J Med, 114, 742, 10.1016/S0002-9343(03)00165-7 Hoffman, 1993, Interaction of catecholamines and nitrous oxide ventilation during incomplete brain ischemia in rats, Anesth Analg, 77, 908, 10.1213/00000539-199311000-00006 Curtis, 2011, Dexmedetomidine and S(+)‐ketamine in ischemia and reperfusion injury in the rat kidney, Acta Cir Bras, 26, 202, 10.1590/S0102-86502011000300008 Yuzer, 2009, Effects of intravenous anesthetics on renal ischemia/reperfusion injury, Renal Failure, 31, 290, 10.1080/08860220902779962 Rusafa Neto, 2006, Influence of S(+)‐ketamine analgesia in renal intraoperative ischemia. Histological study in rats, Acta Cir Bras, 21, 242, 10.1590/S0102-86502006000400010 Lee, 2004, Differential protective effects of volatile anesthetics against renal ischemia‐reperfusion injury in vivo, Anesthesiology, 101, 1313, 10.1097/00000542-200412000-00011